• According to Transparency Market Research’s latest report on the global genome engineering market for the historical period 2017–2018 and forecast period 2019–2027, increased funding in genomic research, technological developments, rising demand for synthetic genes, and investment by pharmaceutical companies for new product development are projected to drive the global genome engineering market during the forecast period
  • According to the report, the global genome engineering market was valued at US$ 3,685.4 Mn in 2018 and is anticipated to expand at a CAGR of 10.9% from 2019 to 2027

To know the scope of our report Get a Sample on Genome Engineering Market

Increased Funding In Genomic Research: Key Drivers

  • Synthetic biology received funding of US$ 430 Mn in the U.S. from 2005 to 2010, which was much higher than US$ 160 Mn in Europe during the same period. The U.K. contributed around US$ 30 Mn. About 4% and 2% funding in the U.S. and Europe, respectively, was spent to explore ethical, social, and legal implications (ELSI) of synthetic biology. Government initiatives are on par with private investments.
  •  More than $700 million was spent on synthetic biology research, by Department of Energy (DOE). While NIH awarded a grant of $40 million for the same.
  • Universities across the globe have provided significant funding for research in synthetic biology. For instance, in 2008, three Dutch universities — Delft University of Technology (Department of Bionanoscience), University of Groningen (Centre for Synthetic Biology), and the Eindhoven University of Technology (Institute for Complex Molecular Systems) — declared they would invest around USD $90 million in synthetic biology research for a period of 5 years to 10 years.
  • Application of genome engineering in animals has increased significantly in the past few years. Usage of this technology brings with it ethical issues that relate to animal welfare.

Get a glimpse of the in-depth analysis through our Report Brochure

Investment by Pharmaceutical Companies for Developing New Treatments Boost Market Growth

  • Pharmaceutical firms have realized the new trends of treating genetic diseases by gene editing technologies. They are collaborating with gene editing companies to develop treatment option.
  • In December 2015, Bayer and CRISPR Therapeutics AG formed a joint agreement, to develop new technology to cure blindness, blood disorders, and congenital heart disease.  Bayer would be utilizing the CRISPR-Cas9 gene editing technology and would use its protein-engineering technology for the same. Bayer will contribute a minimum of USD 300 million in R&D investments in this joint venture.
  •  In January 2015, Novartis formed a collaboration with Intellia and Caribou, which would help Novartis to use CRISPR genome editing technology to engineer chimeric antigen receptor (CAR) T cells and hematopoietic stem cells and also to discover and develop other medicine. This collaboration received an undisclosed amount from Novartis and USD $15 million from both Intellia and Caribou.

 Stringent Regulatory Framework to Hamper Market

  • There are various regulatory frameworks for genetically modifying plant genome. Process based regulatory frameworks consider the techniques used to create new crop plant varieties. The regulation is triggered when the plant is developed by using recombinant DNA technology. The definitions and guidelines for regulation was decided by the organizations such as the United Nations Food and Agricultural Organization and treaties such as the Cartagena protocol. The regulation is followed in Europe, Argentina, Brazil, and several other regions. The product based regulatory framework that prevails in the U.S. and Canada primarily focuses on the inherent risk of the final product, rather than the technology used to make it.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Genome engineering Market: Competitive Landscape

  • This report profiles major players in the global genome engineering market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The major players operating in the global genome engineering market are
    • Applied Stem Cell, Inc.
    • GenScript
    • Horizon Discovery Group plc
    • Integrated DNA Technologies, Inc.
    • Lonza Group Ltd.
    • New England Biolabs
    • OriGene Technologies, Inc.
    • Sangamo BioSciences, Inc.
    • Sigma-Aldrich Co. LLC.
    • Thermo Fisher Scientific, Inc.,
    • Transposagen Biopharmaceuticals, Inc.

Global Genome engineering Market: Key Developments

  • In January 2015,  four research collaborations with The Wellcome Trust Sanger Institute, The Innovative Genomics Initiative, California, Thermo Fisher Scientific, Waltham, Massachusetts and Broad Institute/Whitehead Institute, Cambridge, Massachusetts to use CRISPR technology to identify and validate new drugs in preclinical models that would resemble human diseases.

The report on the global genome engineering market discussed individual strategies, followed by company profile of manufacturer of genome engineering. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global genome engineering market.

Global Genome engineering Market - Segmentation

Technology

Clustered regularly interspaced short palindromic repeats (CRISPR)

Transcription activator-like effector nuclease (Talen)

Zinc Finger Nuclease (ZFN)

Other Technologies

Application

Cell Line Engineering

Animal Genome Engineering

Plant Genome Engineering

Other Application

End-user

Pharmaceutical and Biotechnology Companies

Academics

Clinical Research Organizations

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

The global genome engineering market was worth US$ 3,685.4 Mn and is projected to reach a value of US$ 9,595.2 Mn by the end of 2027

Genome engineering market is anticipated to grow at a CAGR of 10.9% during the forecast period

North America accounted for a major share of the global genome engineering market

Genome engineering market is driven by increased funding in genomic research, technological developments, rising demand for synthetic genes, and investment by pharmaceutical companies for new product development

Key players in the global genome engineering market include Applied Stem Cell, Inc., GenScript, Horizon Discovery Group plc, Integrated DNA Technologies, Inc., Lonza Group Ltd., New England Biolabs, OriGene Technologies, Inc., Sangamo BioSciences, Inc., Sigma-Aldrich Co. LLC., Thermo Fisher Scientific, Inc., and Transposagen Biopharmaceuticals, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Genome Engineering Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Genome Engineering Market Analysis and Forecasts, 2018–2030

5. Key Insights

    5.1. Technological Advancements

    5.2. Healthcare Industry Overview

6. Global Genome Engineering Market Analysis and Forecasts, By Technology 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value  Forecast By Technology, 2018–2030

        6.3.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

        6.3.2. Transcription activator-like effector nuclease (Talen) 

        6.3.3. Zinc Finger Nuclease (ZFN) 

        6.3.4. Others

    6.4. Market Attractiveness By Technology 

7. Global Genome Engineering Market Analysis and Forecasts, By Application 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value  Forecast By Application, 2018–2030

        7.3.1. Cell Line Engineering 

        7.3.2. Animal Genome Engineering 

        7.3.3. Plant Genome Engineering 

        7.3.4. Others

    7.4. Market Attractiveness By Application 

8. Global Genome Engineering Market Analysis and Forecasts, By End-user 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value  Forecast By End-user, 2018–2030

        8.3.1. Pharmaceutical and Biotechnology Companies

        8.3.2. Academics

        8.3.3. Clinical Research Organizations

    8.4. Market Attractiveness By End-user 

9. Global Genome Engineering Market Analysis and Forecasts, By Region

    9.1. Key Findings

    9.2. Market Value  Forecast By Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Market Attractiveness By Region

10. North America Genome Engineering Market Analysis and Forecast

    10.1. Introduction

    10.2. Market Value  Forecast By Technology, 2018–2030

        10.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

        10.2.2. Transcription activator-like effector nuclease (Talen) 

        10.2.3. Zinc Finger Nuclease (ZFN) 

        10.2.4. Others

    10.3. Market Value  Forecast By Application, 2018–2030

        10.3.1. Cell Line Engineering 

        10.3.2. Animal Genome Engineering 

        10.3.3. Plant Genome Engineering 

        10.3.4. Others

    10.4. Market Value  Forecast By End-user, 2018–2030

        10.4.1. Pharmaceutical and Biotechnology Companies

        10.4.2. Academics

        10.4.3. Clinical Research Organizations

    10.5. Market Value  Forecast By Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis 

        10.6.1. By Technology 

        10.6.2. By Application 

        10.6.3. By End-user 

        10.6.4. By Country

11. Europe Genome Engineering Market Analysis and Forecast

    11.1. Introduction

    11.2. Market Value  Forecast By Technology, 2018–2030

        11.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

        11.2.2. Transcription activator-like effector nuclease (Talen) 

        11.2.3. Zinc Finger Nuclease (ZFN) 

        11.2.4. Others

    11.3. Market Value  Forecast By Application, 2018–2030

        11.3.1. Cell Line Engineering 

        11.3.2. Animal Genome Engineering 

        11.3.3. Plant Genome Engineering 

        11.3.4. Others

    11.4. Market Value  Forecast By End-user, 2018–2030

        11.4.1. Pharmaceutical and Biotechnology Companies

        11.4.2. Academics

        11.4.3. Clinical Research Organizations

    11.5. Market Value  Forecast By Country, 2018–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis 

        11.6.1. By Technology 

        11.6.2. By Application 

        11.6.3. By End-user 

        11.6.4. By Country

12. Asia Pacific Genome Engineering Market Analysis and Forecast

    12.1. Introduction

    12.2. Market Value  Forecast By Technology, 2018–2030

        12.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

        12.2.2. Transcription activator-like effector nuclease (Talen) 

        12.2.3. Zinc Finger Nuclease (ZFN) 

        12.2.4. Others

    12.3. Market Value  Forecast By Application, 2018–2030

        12.3.1. Cell Line Engineering 

        12.3.2. Animal Genome Engineering 

        12.3.3. Plant Genome Engineering 

        12.3.4. Others

    12.4. Market Value  Forecast By End-user, 2018–2030

        12.4.1. Pharmaceutical and Biotechnology Companies

        12.4.2. Academics

        12.4.3. Clinical Research Organizations

    12.5. Market Value  Forecast By Country, 2018–2030

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis 

        12.6.1. By Technology 

        12.6.2. By Application 

        12.6.3. By End-user 

        12.6.4. By Country

13. Latin America Genome Engineering Market Analysis and Forecast

    13.1. Introduction

    13.2. Market Value  Forecast By Technology, 2018–2030

        13.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

        13.2.2. Transcription activator-like effector nuclease (Talen) 

        13.2.3. Zinc Finger Nuclease (ZFN) 

        13.2.4. Others

    13.3. Market Value  Forecast By Application, 2018–2030

        13.3.1. Cell Line Engineering 

        13.3.2. Animal Genome Engineering 

        13.3.3. Plant Genome Engineering 

        13.3.4. Others

    13.4. Market Value  Forecast By End-user, 2018–2030

        13.4.1. Pharmaceutical and Biotechnology Companies

        13.4.2. Academics

        13.4.3. Clinical Research Organizations

    13.5. Market Value  Forecast By Country, 2018–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis 

        13.6.1. By Technology 

        13.6.2. By Application 

        13.6.3. By End-user 

        13.6.4. By Country

14. Middle East & Africa Genome Engineering Market Analysis and Forecast

    14.1. Introduction

    14.2. Market Value  Forecast By Technology, 2018–2030

        14.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

        14.2.2. Transcription activator-like effector nuclease (Talen) 

        14.2.3. Zinc Finger Nuclease (ZFN) 

        14.2.4. Others

    14.3. Market Value  Forecast By Application, 2018–2030

        14.3.1. Cell Line Engineering 

        14.3.2. Animal Genome Engineering 

        14.3.3. Plant Genome Engineering 

        14.3.4. Others

    14.4. Market Value  Forecast By End-user, 2018–2030

        14.4.1. Pharmaceutical and Biotechnology Companies

        14.4.2. Academics

        14.4.3. Clinical Research Organizations

    14.5. Market Value  Forecast By Country, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis 

        14.6.1. By Technology 

        14.6.2. By Application 

        14.6.3. By End-user 

        14.6.4. By Country

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis By Company (2019)

    15.3. Company Profiles

        15.3.1. Applied Stem Cell, Inc.

        15.3.2. GenScript

        15.3.3. Horizon Discovery Group plc 

        15.3.4. Integrated DNA Technologies, Inc. 

        15.3.5. Lonza Group Ltd.

        15.3.6. New England Biolabs 

        15.3.7. OriGene Technologies, Inc.

        15.3.8. Sangamo BioSciences, Inc. 

        15.3.9. Sigma-Aldrich Co. LLC. 

        15.3.10. Thermo Fisher Scientific, Inc.

        15.3.11. Transposagen Biopharmaceuticals, Inc.

List of Table

Table 01 Genome engineering Market Size (US$ Mn) Forecast, By Technology, 2019–2027

Table 02 Genome engineering Market Size (US$ Mn) Forecast, By Application, 2019–2027

Table 03 Genome engineering Market Size (US$ Mn) Forecast, By End-user, 2019–2027

Table 04 Genome engineering Market Size (US$ Mn) Forecast, By Geography, 2019–2027

Table 05 North America Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

Table 06 North America Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027

Table 07 North America Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

Table 08 Europe Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

Table 09 Europe Genome engineering Market Size (US$ Mn) and Forecast, By Application, 2019–2027

Table 10 Europe Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

Table 11 Asia Pacific Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

Table 12 Asia Pacific Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027

Table 13 Asia Pacific Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

Table 14 Latin America Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

Table 15 Latin America Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027

Table 16 Latin America Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

Table 17 Middle East & Africa Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027

Table 18 Middle East & Africa Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027

Table 19 Middle East & Africa Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027

List of Figure

Figure 01 Genome engineering Market Snapshot

Figure 02 Genome engineering Market Size (US$ Mn) and Forecast, 2019–2027

Figure 03 Genome engineering Technology Market Revenue (US$ Mn) and Y-o-Y growth (%), 2019–2027

Figure 04 Genome engineering Market Attractiveness Analysis By Technology

Figure 05 Genome engineering Market Attractiveness Analysis By Application

Figure 06 Genome engineering Market Attractiveness Analysis By End-user

Figure 07 North America Genome engineering Value Share Analysis, By Technology, 2019 and 2027

Figure 08 North America Genome engineering Value Share Analysis, By Application, 2019 and 2027

Figure 09 North America Genome engineering Value Share Analysis, By End-user, 2019 and 2027

Figure 10 Europe Genome engineering Value Share Analysis, By Technology, 2019 and 2027

Figure 11 Europe Genome engineering Value Share Analysis, By Application, 2019 and 2027

Figure 12 Europe Genome engineering Value Share Analysis, By End-user, 2019 and 2027

Figure 13 Asia Pacific Genome engineering Value Share Analysis, By Technology, 2019 and 2027

Figure 14 Asia Pacific Genome engineering Value Share Analysis, By Application, 2019 and 2027

Figure 15 Asia Pacific Genome engineering Value Share Analysis, By End-user, 2019 and 2027

Figure 16 Latin America Genome engineering Value Share Analysis, By Technology, 2019 and 2027

Figure 17 Latin America Genome engineering Value Share Analysis, By Application, 2019 and 2027

Figure 18 Latin America Genome engineering Value Share Analysis, By End-user, 2019 and 2027

Figure 19 Middle East & Africa Genome engineering Value Share Analysis, By Technology, 2019 and 2027

Figure 20 Middle East & Africa Genome engineering Value Share Analysis, By Application, 2019 and 2027

Figure 21 Middle East & Africa Genome engineering Value Share Analysis, By End-user, 2019 and 2027

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Genome Engineering Market